Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: Towards a better posttransplant monitoring

Cell Transplantation

Volumn 21, Issue 11, 2012, Pages 2339-2350

  Lacotte, Stéphanie ^a   Borot, Sophie ^a   Ferrari Lacraz, Sylvie ^a   Villard, Jean ^a   Demuylder Mischler, Sandrine ^a   Oldani, Graziano ^a   Morel, Philippe ^a   Mentha, Gilles ^a   Berney, Thierry ^a   Toso, Christian ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cytokine; Diabetes; ELISpot; Islet; Monitoring; Transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 5; KI 67 ANTIGEN;

ALLOIMMUNITY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT RECIPIENT; HUMAN; IMMUNOREACTIVITY; LIMIT OF QUANTITATION; MALE; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER T CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; CELL PROLIFERATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84871546112     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655000     Document Type: Article

References (38)

1. +, alloanti gen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype. Transplantation 70:1641-1649; 2000.
2. Bosi, E.; Braghi, S.; Maffi, P.; Scirpoli, M.; Bertuzzi, F.; Pozza, G.; Secchi, A.; Bonifacio, E. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 50:2464-2471; 2001.
3. Campbell, P. M.; Salam, A.; Ryan, E. A.; Senior, P.; Paty, B. W.; Bigam, D.; McCready, T.; Halpin, A.; Imes, S.; Al Saif, F.; Lakey, J. R. T.; Shapiro, A. M. J. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am. J. Transplant. 7:1242-1248; 2007.
4. Eich, T.; Eriksson, O.; Lundgren, T. Visualization of early engraftment in clinical islet transplantation by positron emission tomography. N. Engl. J. Med. 356:2754-2755; 2007.
5. Emamaullee, J. A.; Davis, J.; Merani, S.; Toso, C.; Elliott, J. F.; Thiesen, A.; Shapiro, A. M. J. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302-1311; 2009.
6. Ferrari-Lacraz, S.; Berney, T.; Morel, P.; Marangon, N.; Hadaya, K.; Demuylder-Mischler, S.; Pongratz, G.; Pernin, N.; Villard, J. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation 86:357-359; 2008.
7. Halloran, P. F.; de Freitas, D. G.; Einecke, G.; Famulski, K. S.; Hidalgo, L. G.; Mengel, M.; Reeve, J.; Sellares, J.; Sis, B. The molecular phenotype of kidney transplants. Am. J. Transplant. 10:2215-2222; 2010.
8. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S.-H.; Zhang, H.-J.; Parkey, J.; Hunter, D. W.; Sutherland, D. E. R. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830-835; 2005.
9. Hilbrands, R.; Huurman, V. A. L.; Gillard, P.; Velthuis, J. H. L.; De Waele, M.; Mathieu, C.; Kaufman, L.; Pipeleers-Marichal, M.; Ling, Z.; Movahedi, B.; Jacobs-Tulleneers-Thevissen, D.; Monbaliu, D.; Ysebaert, D.; Gorus, F. K.; Roep, B. O.; Pipeleers, D. G.; Keymeulen, B. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58:2267-2276; 2009.
10. Hricik, D. E.; Rodriguez, V.; Riley, J.; Bryan, K.; Tary-Lehmann, M.; Greenspan, N.; Dejelo, C.; Schulak, J. A.; Heeger, P. S. Enzyme linked immunosorbent spot (ELISpot) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am. J. Transplant. 3:878-884; 2003.
11. Huurman, V. A. L.; Hilbrands, R.; Pinkse, G. G. M.; Gillard, P.; Duinkerken, G.; van de Linde, P.; van der Meer-Prins, P. M. W.; Versteeg-van der Voort Maarschalk, M. F. J.; Verbeeck, K.; Alizadeh, B. Z.; Mathieu, C.; Gorus, F. K.; Roelen, D. L.; Claas, F. H. J.; Keymeulen, B.; Pipeleers, D. G.; Roep, B. O. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 3:e2435; 2008.
12. Huurman, V. A. L.; Velthuis, J. H. L.; Hilbrands, R.; Tree, T. I. M.; Gillard, P.; van der Meer-Prins, P. M. W.; Duinkerken, G.; Pinkse, G. G. M.; Keymeulen, B.; Roelen, D. L.; Claas, F. H. J.; Pipeleers, D. G.; Roep, B. O. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am. J. Transplant. 9:382-388; 2009.
13. Jaeger, C.; Brendel, M. D.; Hering, B. J.; Eckhard, M.; Federlin, K.; Bretzel, R. G. IA2 antibodies are only positive in association with GAD 65 and islet cell antibodies in islet transplanted insulin-dependent diabetes mellitus patients. Transplant. Proc. 30:659-660; 1998.
14. Keymeulen, B.; Ling, Z.; Gorus, F. K.; Delvaux, G.; Bouwens, L.; Grupping, A.; Hendrieckx, C.; Pipeleers-Marichal, M.; Van Schravendijk, C.; Salmela, K.; Pipeleers, D. G. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459; 1998.
15. Lacotte, S.; Berney, T.; Shapiro, A. J.; Toso, C. Immune monitoring of pancreatic islet graft: Towards a better understanding, detection and treatment of harmful events. Expert Opin. Biol. Ther. 11:55-66; 2011.
16. Lindley, S.; Dayan, C. M.; Bishop, A.; Roep, B. O.; Peakman, M.; Tree, T. I. M. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54:92-99; 2005.
17. Loverre, A.; Tataranni, T.; Castellano, G.; Divella, C.; Battaglia, M.; Ditonno, P.; Corcelli, M.; Mangino, M.; Gesualdo, L.; Schena, F. P.; Grandaliano, G. IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am. J. Transplant. 11:1248-1259; 2011.
18. Mhoyan, A.; Wu, G. D.; Kakoulidis, T. P.; Que, X.; Yolcu, E. S.; Cramer, D. V.; Shirwan, H. Predominant expression of the Th2 response in chronic cardiac allograft rejection. Transpl. Int. 16:464-473; 2003.
19. Mohanakumar, T.; Narayanan, K.; Desai, N.; Ramachandran, S.; Shenoy, S.; Jendrisak, M.; Susskind, B. M.; Olack, B.; Benshoff, N.; Phelan, D. L.; Brennan, D. C.; Fernandez, L. A.; Odorico, J. S.; Polonsky, K. S. A significant role for histocompatibility in human islet transplantation. Transplantation. 82:180-187; 2006.
20. Monti, P.; Scirpoli, M.; Maffi, P.; Ghidoli, N.; De Taddeo, F.; Bertuzzi, F.; Piemonti, L.; Falcone, M.; Secchi, A.; Bonifacio, E. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J. Clin. Invest. 118:1806-1814; 2008.
21. Nath, D. S.; Tiriveedhi, V.; Basha, H. I.; Phelan, D.; Moazami, N.; Ewald, G. A.; Mohanakumar, T. A role for antibodies to human leukocyte antigens, collagen-v, and k-a1-tubulin in antibody-mediated rejection and cardiac allograft vascu lopathy. Transplantation 91:1036-1043; 2011.
22. Nickel, P.; Presber, F.; Bold, G.; Biti, D.; Schönemann, C.; Tullius, S. G.; Volk, H.-D.; Reinke, P. Enzyme-linked immunosorbent spot assay for donor-reactive interferon gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal transplant recipients. Transplantation 78:1640-1646; 2004.
23. Pattou, F.; Kerr-Conte, J.; Wild, D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N. Engl. J. Med. 363:1289-1290; 2010.
24. Roelen, D. L.; Huurman, V. A. L.; Hilbrands, R.; Gillard, P.; Duinkerken, G.; van der Meer-Prins, P. W. M.; Versteeg-van der Voort Maarschalk, M. F. J.; Mathieu, C.; Keymeulen, B.; Pipeleers, D. G.; Roep, B. O.; Claas, F. H. J. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Clin. Exp. Immunol. 156:141-148; 2009.
25. Roep, B. O.; Stobbe, I.; Duinkerken, G.; van Rood, J. J.; Lernmark, A.; Keymeulen, B.; Pipeleers, D.; Claas, F. H.; de Vries, R. R. Auto and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 48:484-490; 1999.
26. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Lakey, J. R. T.; Bigam, D.; Shapiro, A. M. J. Beta-score: An assessment of beta-cell function after islet transplantation. Diabetes Care 28:343-347; 2005.
27. Sabat, R.; Grütz, G.; Warszawska, K.; Kirsch, S.; Witte, E.; Wolk, K.; Geginat, J. Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331-344; 2010.
28. Toso, C.; Baertschiger, R.; Morel, P.; Bosco, D.; Armanet, M.; Wojtusciszyn, A.; Badet, L.; Philippe, J.; Becker, C. D.; Hadaya, K.; Majno, P.; Bühler, L.; Berney, T. Sequential kidney/islet transplantation: Efficacy and safety assessment of a steroid-free immunosuppression protocol. Am. J. Transplant. 6:1049-1058; 2006.
29. Toso, C.; Edgar, R.; Pawlick, R.; Emamaullee, J.; Merani, S.; Dinyari, P.; Mueller, T. F.; Shapiro, A. M. J.; Anderson, C. C. Effect of different induction strategies on effector, regulatory and memory lymphocyte subpopulations in clinical islet transplantation. Transpl. Int. 22:182-191; 2009.
30. Toso, C.; Isse, K.; Demetris, A. J.; Dinyari, P.; Koh, A.; Imes, S.; Kin, T.; Emamaullee, J.; Senior, P.; Shapiro, A. M. J. Histologic graft assessment after clinical islet transplantation. Transplantation 88:1286-1293; 2009.
31. Toso, C.; Oberholzer, J.; Ris, F.; Triponez, F.; Bucher, P.; Demirag, A.; Andereggen, E.; Buehler, L.; Cretin, N.; Fournier, B.; Majno, P.; Hong, Y.; Lou, J.; Morel, P. Factors affecting human islet of Langerhans isolation yields. Transplant. Proc. 34:826-827; 2002.
32. Toso, C.; Pawlick, R.; Lacotte, S.; Edgar, R.; Davis, J.; McCall, M.; Morel, P.; Mentha, G.; Berney, T.; Shapiro, A. M. J. Detecting rejection after mouse Islet transplantation utilizing islet protein-t ELISpot. Cell Transplant. 20:955-962; 2011.
33. Toso, C.; Vallee, J.-P.; Morel, P.; Ris, F.; Demuylder-Mischler, S.; Lepetit-Coiffe, M.; Marangon, N.; Saudek, F.; James Shapiro, A. M.; Bosco, D.; Berney, T. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am. J. Transplant. 8:701-706; 2008.
34. Toso, C.; Zaidi, H.; Morel, P.; Armanet, M.; Andres, A.; Pernin, N.; Baertschiger, R.; Slosman, D.; Bühler, L. H.; Bosco, D.; Berney, T. Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation 79:353-355; 2005.
35. van den Boogaardt, D. E. M.; van Miert, P. P. M. C.; de Vaal, Y. J. H.; de Fijter, J. W.; Claas, F. H. J.; Roelen, D. L. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 82:844-848; 2006.
36. van Kampen, C. A.; van de Linde, P.; Duinkerken, G.; van Schip, J. J.; Roelen, D. L.; Keymeulen, B.; Pipeleers, D. G.; Claas, F. H. J.; Roep, B. O. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. Transplantation 80:118-126; 2005.
37. + T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59:1721-1730; 2010.
38. Wang, M.; Yang, L.; Sheng, X.; Chen, W.; Tang, H.; Sheng, H.; Xi, B.; Qin Zang, Y. T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORg t inhibition in autoimmune diabetes. Cell Res. 21:1358-1369; 2011.